The intervention may leads to higher MMRV vs MMR+V ‐ by brand ‐ from 7 to 10 days after vaccination… (low certainty).
The intervention showed no clear difference in MMRV vs MMR ‐ by brand ‐ from 0 to 42 days after vaccination… (low certainty).
The intervention may leads to higher MMRV vs MMR ‐ by brand ‐ from 7 to 10 days after vaccination… (low certainty).
The intervention may leads to higher MMRV vs MMR ‐ by brand ‐ from 0 to 42 days after vaccination (ProQuad) (low certainty).
The intervention may leads to higher MMRV vs MMR ‐ by brand ‐ from 7 to 10 days after vaccination (ProQuad) (low certainty).
The intervention showed no clear difference in self‐controlled case series (hospitalisations) ‐ hospitalisations ‐… (low certainty).
The intervention may leads to higher self‐controlled case series (GP visits) ‐ GP visit ‐ risk period: 0… (low certainty).
The intervention showed no clear difference in self‐controlled case series (GP visits) ‐ GP visit ‐ risk period: 6… (low certainty).
The intervention may leads to lower self‐controlled case series ‐ lobar pneumonia ‐ lobar pneumonia risk… (low certainty).
The intervention showed no clear difference in self‐controlled case series ‐ invasive bacterial infections ‐… (low certainty).
Atovaquone‐proguanil showed no clear difference in total failure day 28 PCR‐adjusted compared with artemether‐lumefantrine (low certainty).
Atovaquone‐proguanil showed no clear difference in total failure day 28 PCR‐unadjusted compared with artesunate‐atovaquone‐proguanil (low certainty).
Atovaquone‐proguanil showed no clear difference in total failure [day 42 PCR‐adjusted compared with artesunate‐atovaquone‐proguanil (moderate certainty).
Atovaquone‐proguanil showed no clear difference in total failure day 42 PCR‐unadjusted compared with artesunate‐atovaquone‐proguanil (moderate certainty).
Atovaquone‐proguanil showed no clear difference in total failure day 42 PCR‐unadjusted compared with artemether‐lumefantrine (low certainty).
Atovaquone‐proguanil showed no clear difference in total failure day 42 PCR‐adjusted compared with artemether‐lumefantrine (low certainty).
Atovaquone‐proguanil showed no clear difference in total failure day 28 PCR‐adjusted compared with artesunate‐amodiaquine (low certainty).
Atovaquone‐proguanil showed no clear difference in total failure day 28 PCR‐unadjusted compared with artesunate‐amodiaquine (low certainty).
Atovaquone‐proguanil showed no clear difference in total failure day 42 PCR‐adjusted compared with artesunate‐mefloquine (high certainty).
Atovaquone‐proguanil showed no clear difference in total failure day 42 PCR‐unadjusted compared with artesunate‐mefloquine (low certainty).